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Abstract
Background—The single spanning transmembrane amyloid precursor protein (APP) and its
proteolytic product, amyloid-beta (Aβ) peptide, have been intensely studied due to their role in the
pathogenesis of Alzheimer’s disease. However, the biological role of the secreted ectodomain of
APP, which is also generated by proteolytic cleavage, is less well understood. Here, we report
Tol2 red fluorescent protein (RFP) transposon gene trap integrations in the zebrafish amyloid
precursor protein a (appa) and amyloid precursor-like protein 2 (aplp2) genes. The transposon
integrations are predicted to disrupt the appa and aplp2 genes to primarily produce secreted
ectodomains of the corresponding proteins that are fused to RFP.
Results—Our results indicate the Appa-RFP and Aplp2 fusion proteins are likely secreted from
the central nervous system and accumulate in the embryonic veins independent of blood flow.
Conclusions—The zebrafish appa and aplp2 transposon insertion alleles will be useful for
investigating the biological role of the secreted form of APP.
Keywords
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INTRODUCTION
Alzheimer’s disease (AD) is the most prevalent form of human dementia, accounting for
60–70% cases worldwide. The neural pathology of AD includes senile plaques,
neurofibrillary tangles, and loss of neurons. In addition, there is a significant vascular
pathology in AD characterized by amyloid deposits in cerebral vessel walls (cerebral
amyloid angiopathy), as well as structural abnormalities in the microvasculature (Revesz et
al., 2003; Bailey et al., 2004; Kumar-Singh, 2008; Storkebaum et al., 2011). The amyloid
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precursor protein (APP) is known to be the source of the hydrophobic peptide amyloid β
(Aβ) that is a major component of amyloid deposits in the brains of AD patients (Kang et
al., 1987; Newman et al., 2007; Philipson et al., 2010). Membrane bound APP is composed
of a large extracellular amino-terminal domain, a single transmembrane domain, and a short
cytoplasmic domain (reviewed in Gralle and Ferreira, 2007; Jacobsen and Iverfeldt, 2009).
The processing of APP involves regulated intramembrane proteolysis, which can be divided
into two major pathways. Approximately 90% of APP proteolytic processing is through the
nonamyloidogenic pathway, in which cleavage of the extracellular domain by α-secretase
releases a soluble form of APP (sAPPα) into the extracellular space. Subsequent cleavage
by γ-secretase releases the sAPPα into the cytoplasm. The remaining 10% of APP
processing occurs by means of the amyloidogenic pathway in which the extracellular
domain is cleaved at a different residue by β-secretase. This releases an alternative
extracellular soluble form, sAPPβ. Cleavage of the remaining membrane bound protein by
γ-secretase releases the hydrophobic Aβ peptide into the extracellular space. Although there
are extensive studies on APP and the Aβ peptide, the in vivo biological function and
localization of secreted sAPP is not completely known, nor is the contribution of sAPP to
the neural and vascular pathogenesis of AD.
Studies in Drosophila and mammalian cell culture systems have implicated sAPP in the
regulation of neurite outgrowth (Small et al., 1994), neuronal survival (Araki et al., 1991)
and neuroprotection (Goodman and Mattson, 1994). In addition, the sAPP peptide is
sufficient to rescue molting and morphogenesis defects from loss of APL-1 in
Caenorhabditis elegans and is suggested to function in a cell-nonautonomous manner
(Hornsten et al., 2007). In mice, a knock-in allele that produces sAPPα exclusively rescues
the postnatal lethality in APP/APLP2 double mutants (Weyer et al., 2011), suggesting that
much of the normal biological function of the APP gene family can be mediated through the
soluble extracellular domains. It is also intriguing that patients with AD display reduced
levels of the sAPPα cleavage peptide (Lannfelt et al., 1995), raising the possibility that the
sAPPα could contribute to the pathogenesis of AD. In humans and mice, the APP genes are
predominantly expressed in neural tissues, and there is little evidence for expression in cell
types other than neurons or ganglia (Goldgaber et al., 1987; Tanzi et al., 1987; Arai et al.,
1991).
The application of Tol2 DNA transposons for gene trap, enhancer trap, and germline
mutagenesis screens is well established in zebrafish (Balciunas and Ekker, 2005; Balciunas
et al., 2006; Kawakami, 2007; Largaespada, 2009; Suster et al., 2009; Ivics and Izsvak,
2010). A major advantage of using gene trap transposons as a mutagen is that the integrated
transposon acts as a molecular tag that facilitates gene cloning. Zebrafish are particularly
well suited to gene trap insertional mutagenesis due to the optical clarity of the embryo and
the amenability of the organism to large-scale screens. Gene trap transposons are engineered
to intercept splicing of the endogenous gene transcript and produce fluorescent proteins that
act as reporters of the normal expression pattern of the mutated gene. This approach, using
red fluorescent protein (RFP) or green fluorescent protein (GFP) trap Tol2 transposons, has
identified many genes with tissue specific patterns of interest in the developing zebrafish
embryo (Balciunas et al., 2004; Kawakami et al., 2004, 2010; Parinov et al., 2004; Choo et
al., 2006; Kawakami, 2007; Sivasubbu et al., 2007; Asakawa and Kawakami, 2009). Recent
modification of the Tol2 gene trap system has yielded a powerful tool for expression as well
as functional annotation of the zebrafish genome (Clark et al., 2011). Live cell imaging of
trapped fluorescent proteins in the zebrafish embryo can yield novel insights into the
biological role of the gene product in a particular cellular or developmental process.
In the present study, we carried out a germline mutagenesis screen using the Tol2 gene trap
GBT-R15 (Petzold et al., 2009) to identify novel genes involved in vascular development in
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the zebrafish embryo. We present an analysis of two of the integration lines that show
accumulation of RFP in the vasculature. Cloning of the integration sites revealed one line
had an insertion in the gene amyloid beta (A4) precursor protein a (appa; Musa et al., 2001)
and the other in the amyloid beta (A4) precursor-like protein 2 (aplp2; Jelen et al., 2007).
Both appa and aplp2 are members of the APP family that encode type I transmembrane
proteins expressed in cells of the central nervous system. In situ hybridization in the
zebrafish embryo demonstrates that appa and aplp2 are expressed in the neurons and ganglia
of the central and peripheral nervous system. The locations of the gene trap insertion sites
are predicted to create fusion proteins that are similar to the normal processing of APP by
the α- or β-secretase pathway to produce the soluble secreted form of APP. Our analysis of
the Appa-RFP and Aplp2-RFP proteins in living zebrafish embryos shows the secreted
soluble proteins accumulate in the venous compartment of the vasculature. The appa and
aplp2 gene trap lines isolated in this study will be useful for investigating the biological
roles of the secreted soluble APP proteins.
RESULTS AND DISCUSSION
Isolation of appa and aplp2 Tol2 Gene Trap Alleles
To identify genes involved in early vascular development, we performed a germline
mutagenesis screen using the Tol2 RFP gene trap GBT-R15 (Petzold et al., 2009). The
GBT-R15 transposon contains a splice acceptor, an RFP lacking the first initiating AUG
codon, and a transcriptional terminator. Out of 227 founder adults, 37 produced progeny
with tissue and cell-type specific patterns of RFP gene expression in the embryo (frequency
of 16%). This frequency is comparable to previously published enhancer trap and gene trap
reports in zebrafish (Balciunas and Ekker, 2005). Four of the 37 lines showed RFP
expression in the embryonic vasculature, named V1–V4. To identify the Tol2 integration
site in the vascular gene trap lines, we performed 5′-rapid amplification of cDNA ends
(RACE) on total RNA isolated from 2 days post fertilization (dpf) RFP expressing embryos.
The 5′-RACE product from line V2 contained the first 4 exons of the zebrafish amyloid beta
(A4) precursor protein a (appa) gene fused to the 5′ end of RFP. The V3 line 5′-RACE
product contained the first 12 exons of the amyloid beta (A4) precursor-like protein 2
(aplp2) gene fused to the 5′ end of RFP. These results indicate that in gene trap line V2 the
Tol2 transposon had integrated into intron 4 of the appa gene (Fig. 1A), while in line V3 the
transposon had integrated into intron 12 of the aplp2 gene (Fig. 1A). Zebrafish appa
(Ensembl(Zv9):ENSDARG00000059036) and aplp2
(Ensembl(Zv9):ENSDARG00000054864) are orthologues of human APP and APLP2,
respectively, and are both members of the amyloid beta (A4) precursor protein family. The
gene trap insertion alleles for the two lines isolated in this study are designated as appais22Gt
and aplp2is23Gt.
To confirm the location of the Tol2 integration sites in lines appais22Gt and aplp2is23Gt,
genomic Southern blot analyses were performed with probes specific to the appa and aplp2
genes, and the Tol2 GBT-R15 transgene. Using a gene-specific probe a larger restriction
fragment length polymorphism (RFLP) is detected in line appais22Gt and aplp2is23Gt (Supp.
Fig. S1A,B, which is available online), as expected based on the predicted location of the
transposon integration site in each gene (Supp. Fig. S1). Genomic Southern analysis on lines
appais22Gt and aplp2is23Gt using a probe complementary to the RFP cDNAdetected a single
RFLP of the expected size in each line (Supp. Fig. S2A,B). Together these results
demonstrate that the RFP expression patterns observed in lines appais22Gt and aplp2is23Gt are
the result of a single Tol2 gene trap integration in the appa and aplp2 genes, respectively.
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Zebrafish App family
The human APP gene family encodes single-pass transmembrane proteins that are cleaved
to produce extracellular and intracellular soluble peptides. The zebrafish appa and aplp2
genes encode proteins that have the same predicted structure, with a large extracellular
domain containing multiple subdomains, a single transmembrane domain, and a short
cytoplasmic tail (Musa et al., 2001; Fig. 1B). The conserved extracellular domain contains
two heparin-binding domains (HBD), a growth factor like domain (GFLD), a metal-binding
domain (Cu/Zn BD), an acidic domain (DE) and a Kunitz protease inhibitor domain (KPI;
Fig. 1B). In addition, the locations of predicted cleavage sites recognized by α-, β-, and γ-
secretases are conserved (Fig. 1B, Supp. Fig. S3). This indicates that the same pathways
likely process the zebrafish proteins as human APP to create the soluble and secreted forms
of APP. The location of the Tol2 gene trap integration in each gene suggests that the Appa-
RFP and Aplp2-RFP gene trap proteins are secreted. The transposon had integrated into an
intron upstream of the exons that code for the single-pass transmembrane domain (Fig.
1A,B; Supp. Fig. S3). The accumulation of the Appa-RFP and Aplp2-RFP trap proteins in
the vasculature in the embryo also supports this (see below). The resulting fusion proteins
are predicted to contain an N-terminal signal sequence that targets them to the secretory
pathway.
In zebrafish, the APP family is composed of four genes (Fig. 2A). There are two orthologues
of APP, named appa and appb, probably originating as a result of the ancient genome
duplication in the teleost lineage (Musa et al., 2001; Joshi et al., 2009). There is a single
orthologue of the APLP1 and APLP2 genes, named aplp and aplp2 (Jelen et al., 2007).
Zebrafish appa is located on chromosome 1 and encodes a 738 amino acid protein with 80%
similarity to human APP (Supp. Fig. S3). Zebrafish aplp2 is located on chromosome 18 and
encodes a 764 amino acid protein with 78% similarity to human APLP-2 (Supp. Fig. S3).
Phylogenetic analysis indicates that APP and APLP2 orthologues are more closely related to
each other than to APLP or the single APP orthologues in C. elegans (apl-1) and Drosophila
(appl; Fig. 2A).
Expression patterns of Zebrafish appa and aplp2
The APP genes are widely expressed in human adult and fetal tissues (Goldgaber et al.,
1987; Tanzi et al., 1987); however, tissues are composed of multiple cell types, and there is
little evidence that the genes are expressed in cell types other than neurons. Although there
is one report of human APP protein localization in endothelial cells of the gut (Cabal et al.,
1995), there are no reports in the literature of APP mRNA expression in vascular cells. A
previous study showed that appa gene expression is first detectable at the mid-gastrula stage
in the zebrafish embryo (Musa et al., 2001). We used reverse transcriptase-polymerase chain
reaction (RT-PCR) to examine the relative expression level of appa and aplp2 in the
developing embryo and adult tissues (Fig. 2B). A low level of appa expression is detected in
1 to 12 hours post fertilization (hpf) embryos. This level increases substantially at 24 hpf,
and remains high through 5 dpf. In contrast, the level of aplp2 is relatively low from day 1
through day 5. In adult tissues, both appa and aplp2 are widely expressed except in the
muscle and liver. The level of expression of appa is higher in the adult brain compared with
aplp2, while aplp2 is higher than appa in the ovary and intestine. These results suggest that
zebrafish appa and aplp2 are widely expressed throughout development, similar to the
human APP gene family.
To identify the cell types that express zebrafish appa and aplp2 during early development,
we performed whole-mount in situ hybridization on wild-type embryos. Zebrafish appa has
previously been shown to be expressed in the developing nervous system at 24 hpf (Musa et
al., 2001). We also observed expression of appa, as well as aplp2, throughout the central
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nervous system at 36 hpf (Fig. 3). Control experiments using appa and aplp2 sense probes
showed no detectable pattern above background (Supp. Fig. S4). Both appa and aplp2 show
very similar patterns in the embryo and are expressed throughout the forebrain, midbrain
and hindbrain (Fig. 3A,G) and along the length of the neural tube (Fig. 3C,F,K). Expression
was also detected in cranial ganglia (Fig. 3B,H), the trigeminal ganglia (Fig. 3H,I) and
anterodorsal and posterior lateral line ganglia (Fig. 3E,I,J). A cross-section through the trunk
shows expression of both genes in the pronephric ducts and the neural tube (Fig. 3F,K). appa
is expressed in the neuromasts of the lateral line (Fig. 3C,F), while a low level of aplp2 is
detected in the floor plate (Fig. 3K, inset). Neither gene is expressed at detectable levels in
the dorsal aorta, caudal vein, vessels in the head or intersegmental vessels of the trunk.
Secreted Appa- and Aplp2-RFP Fusion Proteins Accumulate at the Zebrafish Embryonic
Vasculature
We examined the localization of the Appa-RFP and Aplp2-RFP fusion proteins by
fluorescence and confocal microscopy in living 36 hpf embryos. Appa-RFP localization is
primarily in the caudal vein but can be detected in some of the intersegmental vessels (Fig.
4A,B). A low level of expression can be detected throughout the central nervous system in
the head and trunk (Fig. 4A). A similar pattern of RFP fluorescence was detected for the
Aplp2-RFP protein in aplp2is23Gt embryos (Fig. 5A,B). Several veins are in close
association with each region of the central nervous system and pronephric ducts where appa
and aplp2 were detected by in situ hybridization. These vessels include the cerebral and
cardinal veins, intersegmental vessels, and the axial vein. It is possible that App-RFP fusion
proteins are secreted by neurons and accumulate in the vessels located nearby. In situ
hybridization with an RFP-specific probe on appais22Gt and aplp2is23Gt 36 hpf embryos
reveals a pattern similar to the endogenous appa and aplp2 genes. A high level of expression
was present in the central nervous system and pronephric ducts, however, no signal was
detected in the endothelial cells of the blood vessels (Supp. Fig. S5). These results are
consistent with the prediction that the Appa-RFP and Aplp2-RFP fusion proteins are
secreted from neuronal cells and cells of the pronephric ducts and subsequently accumulate
at the embryonic vasculature.
To confirm that Appa-RFP and Aplp2-RFP localization is restricted to the venous vessels,
we created double transgenic embryos using a line that expresses a GFP fusion protein in
endothelial cells of both arteries and veins. The transgenic line Tg(flk1:moesin-egfp)is1
(Wang et al., 2010) expresses a Moesin1-GFP fusion protein under the control of the flk1
promoter, which results in expression in the endothelial cells of the vasculature (Jin et al.,
2005). The appais22Gt and aplp2is23Gt lines were crossed to Tg(flk1:moesin-egfp)is1 and
living embryos imaged by confocal microscopy. Similar results were observed in
appais22Gt/+; Tg(flk1:moesin-egfp)is1/+ (Fig. 4) and aplp2is23Gt/+; Tg(flk1:moesin-egfp)is1/+
embryos (Fig. 5). Comparison of GFP and RFP localization in the trunk showed overlap
only in the posterior caudal vein and the ventral region of the intersegmental vessels (Figs.
4C,D, 5C,D). In the head, GFP was detected throughout the veins and arteries, whereas RFP
was primarily in the veins, including the common cardinal vein, midcerebral vein (MCeV),
and the primordial hindbrain channel (PHBC; Figs. 4E,F, 5E,F). We confirmed the
localization of RFP in the veins by immunolocalization of RFP in fixed 36 hpf transgenic
embryos. A cross-section through the trunk shows RFP enriched at the posterior caudal vein
but absent from the neural tube and posterior lateral line ganglia (Figs. 4H, 5H). Confocal
microscopy of double transgenic living embryos suggested that Appa-RFP and Aplp2-RFP
fusion proteins were localized to both the luminal and abluminal surface of the endothelial
cells of the posterior caudal vein, as well as in intracellular regions possibly corresponding
to endocytic vesicles (Figs. 4G,I, 5G,I).
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Examination of Appa-RFP and Aplp2-RFP protein localization in embryos at earlier stages
of development is consistent with the in situ hybridization data indicating expression is
primarily restricted to neural tissues. Appa-RFP and Aplp2-RFP showed accumulation in
locations in which blood vessels had not yet formed. At 24 hpf, Appa-RFP is detected at a
low level throughout the neural tube and central nervous system (Supp. Fig. S6A–D). In the
head Appa-RFP is enriched in an area around the lens in the eye (Supp. Fig. S6A,B, yellow
arrows). Appa-RFP is also enriched at the somite boundaries in the trunk (Supp. Fig. S6C,D,
yellow arrows), before the intersegmental vessels have completely formed. Later, at 28 hpf,
Appa-RFP is detected in the region of the posterior caudal vein (Supp. Fig. 6G,H, white
arrows). Similar results were observed with Aplp2-RFP protein localization (data not
shown). Taken together, these results suggest that the Appa-RFP and Aplp2-RFP fusion
proteins are not expressed in vascular cells, but instead are expressed in neurons, ganglia,
and cells of the pronephros and are secreted. These results are consistent with studies of
human β-APP that detected the presence of the proteins in neural tissues and only a few
nonneural tissues, namely the pituitary and adrenal glands and cardiac muscle (Arai et al.,
1991). The expression patterns in zebrafish indicate that following production in the
neurons, the secreted Appa-RFP and Aplp2-RFP fusion proteins become enriched at the
venous vessels in the embryo after 28 hpf.
Appa-RFP and Aplp2-RFP Are Localized to Blood Vessels in the Absence of Blood Flow
We next tested whether blood flow was required for the accumulation of the fusion proteins
in the veins by crossing the gene trap alleles into a silent heartmn0031Gt (sihmn0031Gt) mutant
background (Clark et al., 2011), which lacks a heartbeat and blood flow due to a mutation in
the cardiac troponin T2a gene, tnnt2a (Sehnert et al., 2002). The appais22Gt/+; sihmn0031Gt/+
or aplp2is23Gt/+; sihmn0031Gt/+ double heterozygous fish were further crossed with
Tg(flk1:moesin1-egfp)is1/+; sihmn0031Gt/+ to generate homozygous appais22Gt/+;
sihmn0031Gt/mn0031Gt or aplp2is23Gt/+; sihmn0031Gt/mn0031Gt mutants in a Tg(flk1:moesin1-
egfp)is1/+ background. Despite the absence of a heartbeat or normal blood flow in
sihmn0031Gt/mn0031Gt homozygous mutant embryos, Appa-RFP and Aplp2-RFP accumulated
at the venous vessels, similar to control heterozygous sihmn0031Gt/+ siblings with a normal
heart beat (Supp. Fig. S7). These results demonstrate that the accumulation of Appa-RFP
and Aplp2-RFP at the veins occurs by a mechanism independent of blood flow.
We followed the expression of the Appa-RFP and Aplp2-RFP fusion proteins in older
animals and found that RFP accumulated in the kidneys beginning at 5 dpf; however, RFP
was still detected at the venous vessels even at 10 dpf (data not shown). Adult fish were
dissected and the organs examined for RFP fluorescence on a standard epi-illumination
microscope. RFP expression was detected in cells embedded in the membrane covering the
brain (Supp. Fig. S8A,B,E–H). These cells are likely to be microglia, which are the resident
macrophages of the central nervous system. RFP expressing cells were also present in the
connective tissue in the ovary and the membrane covering the spleen (data not shown). RFP
was not detected in muscle, liver, skin, intestine, or spleen. Consistent with the expression of
Appa-RFP and Aplp2-RFP in older larvae, RFP was highly expressed throughout the kidney
tubules (Supp. Fig. S8C–E,J).
The localization of Appa-RFP and Aplp2-RFP is distinct from the mRNA expression
patterns of appa and aplp2, suggesting that the fusion proteins are secreted by nonvascular
cells and then accumulate at the veins. Because both fusion proteins contain nearly the entire
N-terminal extracellular domain, similar to the soluble secreted form of sAPP, it is possible
that the conserved subdomains (i.e., heparin binding/growth factor like, metal binding,
acidic, or KPI domains) are responsible for the binding of the fusion proteins to the
extracellularmatrix at the veins. Studies of the extracellular domain of APP indicate APP
functions as an adhesion molecule/contact receptor, has the ability to self-dimerize, and
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binds to specific components of the extracellular matrix including collagen, heparin-sulfate
proteoglycans, and F-spondin (Gralle and Ferreira, 2007; Jacobsen and Iverfeldt, 2009).
Release of the intracellular domain of APP by the γ-secretase pathway is stimulated by
binding of the extracellular domain to the GPI-linked ligand TAG1 (Ma et al., 2008), similar
to the processing of other type-1 transmembrane proteins such as Notch. Fibulin-1, a
member of the fibulin family of secreted glycoproteins that are components of basement
membrane, has been shown to bind APP’s amino-terminal growth factor-like domain; this
interaction contributes to the neurotrophic activities of APP (Ohsawa et al., 2001). In
addition, Fibulin-1 and fibulin-5 have been shown to suppress angiogenesis in tumors
derived from mice injected with HT1080 cancer cells (Xie et al., 2008). Fibulin-1 knock-out
mice presented with a severe perinatal lethal phenotype with structural defects in endothelial
cells of the microvasculature (Kostka et al., 2001). It is possible that sAPP might bind
fibulin-1 in the vascular basement membrane in zebrafish, and this interaction could account
for the localization of the Appa-RFP and Aplp2-RFP fusion proteins at the embryonic veins.
Binding to other components of the extracellular matrix could also contribute to the
localization of Appa-RFP and Aplp2-RFP in the zebrafish embryo.
Previous analyses of the zebrafish appb gene demonstrated that endogenous appb is
expressed in the central nervous system (Musa et al., 2001), while an appb promoter-GFP
transgene revealed GFP present throughout the nervous system and the embryonic
vasculature (Lee and Cole, 2007). Our present study demonstrates that endogenous appa and
aplp2 are expressed primarily in the central and peripheral nervous system, and in the
pronephric ducts of the developing kidney, but not in the vasculature. Our results for appa
are consistent with previous analyses of zebrafish appa and appb (Musa et al., 2001), and of
human and mouse APP genes (Goldgaber et al., 1987; Tanzi et al., 1987; Arai et al., 1991).
Studies on Presenilin-1 (PS1), one of three genes (APP, PS1, and Presenilin-2) known to be
mutated in familial AD, suggest that signaling between neuronal and vascular tissues plays a
role in the pathology of AD. Gama-Sosa et al. have shown that transgenic mice
overexpressing a mutant form of human PS1 develop vascular pathologies (Gama Sosa et
al., 2010). The PS1 transgene is specifically expressed in neural cells and is absent from
vascular endothelial cells (Gama Sosa et al., 2010). Our similar findings on zebrafish appa
and aplp2 expression suggest the appais22Gt and aplp2is23Gt alleles could provide new
insights into the role of secreted App proteins in vascular biology and the mechanism
linking the neural and vascular pathologies of Alzheimer’s disease.
In a recent study, the knockdown of appb was shown to cause defective convergent
extension movements in zebrafish embryos, while knockdown of appa had no apparent
effect on development (Joshi et al., 2009). The zebrafish appais22Gt and aplp2is23Gt insertion
alleles isolated in the present study are homozygous viable, consistent with the previously
published morpholino knockdown experiments. The lack of an obvious phenotype could be
due to functional redundancy among APP family members in zebrafish. This could also be a
result of low amounts of wild-type appa and aplp2 transcripts present in homozygous
appais22Gt/is22Gt and aplp2is23Gt/is23Gt embryos, as detected by RT-PCR (Supp. Figs. S9C,
S10C). This indicates that the gene trap alleles do not completely disrupt normal splicing of
the gene and are not null alleles. Moreover, the production of soluble Appa-RFP and Aplp2-
RFP fusion proteins may compensate for the loss of the full-length Appa and Aplp2
proteins, similar to studies in mice (Weyer et al., 2011). The ligand binding and adhesive
activity of the extracellular domain of APP is important for its role in synaptogenesis, cell
adhesion, and neurite outgrowth, but the exact biological function remains unclear (Jacobsen
and Iverfeldt, 2009). The secreted App-RFP proteins expressed by the zebrafish appais22Gt
and aplp2is23Gt gene trap alleles isolated in our study will be useful for investigating further
the biological function of APP.
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EXPERIMENTAL PROCEDURES
Zebrafish Husbandry and Strains
Wild-type and WIK strains of zebrafish were housed in an AHAB system (Aquatic
Ecosystems, Inc., Apopka, FL) and maintained under a 14-hr light /10-hr dark cycle at 27°C.
The WIK zebrafish strain was obtained from the Zebrafish International Research Center
(http://zebrafish.org/zirc/home/guide.php). The silent heartmn0031Gt allele contains a Tol2
gene trap integration in the cardiac tropinin T gene (Clark et al., 2011) and was obtained
from Darius Balciunas, Temple University. The Tg(flk1:moesin-egfp)is1 line was described
previously (Wang et al., 2010). Embryos were collected following fertilization and allowed
to develop in a 28.5°C incubator under standard laboratory conditions. For in situ
hybridization experiments, the embryos were placed in fish water (60.5 mg salts/l)
containing 0.003% 1-phenyl-2-thiourea (PTU) to inhibit pigment formation in melanocytes.
Staging of embryos was as published (Kimmel et al., 1995).
Embryo Injections for the Germline Insertional Mutagenesis Screen
Capped Tol2 transposase mRNA was synthesized in vitro from 1 μg of linearized pT3TS-
Tol2 plasmid template (Balciunas et al., 2006) using the mMESSAGE mMACHINE High
Yield Capped RNA transcription kit (Ambion, Cat. No. AM1348) and purified using the
RNeasy MinElute Cleanup Kit (Qiagen). The GBT-R15 Tol2 RFP gene trap plasmid
(Petzold et al., 2009) was propagated in bacteria and purified using the QIAPrep spin
column kit (Qiagen). The mRNA and plasmid DNA were diluted in water, and 50 pg of
GBT-R15 plasmid DNA and 300 pg of Tol2 mRNA were coinjected into 1-cell embryos.
227 injected embryos were raised to adulthood. Adults were intercrossed or outcrossed with
WIK, and the F1 progeny were screened for RFP expression from the Tol2 gene trap at 24
and 48 hpf. F1 embryos for each Tol2 integration line were raised to adulthood, and
subsequent generations maintained by outcrossing with WIK.
Computational Analysis
Protein sequence alignment was performed using Clustal W (Swiss Institute of
Bioinformatics). Phylogenetic tree construction was carried out using MEGA4: Molecular
Evolutionary Genetics Analysis (MEGA) software (Tamura et al., 2007).
In Situ Hybridization and Confocal Imaging
Whole-mount in situ hybridization on zebrafish embryos and larvae was performed using
digoxigenin antisense RNA probes as described previously (Larson et al., 2004). appa and
aplp2 cDNAs were amplified by PCR using the following primers: appa, forward 5′-
TGTGGAGTTCGTGTGCTGTC-3′; appa, reverse 5′-CGTGATGACGATGATGGTTG-3′;
aplp2, forward 5′-CCCTGTGGCATCGATAAGTT-3′; and aplp2, reverse 5′-
CCGTACTGCCTCTTCCTCAG-3′. The PCR products were cloned into the pCRII TOPO
vector. A 541-bp fragment of the RFP was amplified from the GBT-R15 plasmid using
primers rfp-L: 5′-CGAGGACGTCATCAAGGAGT-3′ and rfp-R: 5′-
CTTGGCCATGTAGGTGGTCT-3′, and cloned into the pCR4 TOPO vector. The cloned
appa, aplp2, and RFP cDNAS were used as template for synthesizing digoxigenin-labeled
antisense and sense RNA probes. Digoxigenin-labeled RNA probes were synthesized by in
vitro transcription in the presence of dig-labeled UTP (Roche) and purified as described
(McGrail et al., 2010). In situ labeled embryos were analyzed on a Zeiss Axioscope using
DIC optics and photographed with a Nikon Coolpix camera. Living embryos were mounted
in 1% low-melting agarose and imaged on a Zeiss LSM 700 confocal microscope. Confocal
z-series were analyzed with Zeiss AxioVision software. The identification of blood vessels
in the embryonic vasculature was determined according to zebrafish anatomy described at
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http://zfish.nichd.nih.gov/zfatlas/FinalDesign1/DiagPage.html and
http://zfin.org/action/anatomy/term-detail?anatomyItem.zdbID=ZDB-ANAT-010921-585.
Immunohistochemistry
Zebrafish embryos were selected for RFP expression and were fixed overnight in 4%
paraformaldehyde in phosphate buffered saline (PBS) at 4°C. Embryos were dechorionated,
dehydrated through an ethanol series and stored at −20°C. Embryos were transferred to
acetone at −20°C for 15 min and washed in H2O with 0.1% Triton X-100 at room
temperature for 5 min. Following two rinses in PBS/0.1% Triton X-100 (PBSTx), embryos
were blocked for one hour at room temperature in 2% sheep serum, 1% bovine serum
albumin (BSA), 1% dimethyl sulfoxide (DMSO), 0.1% Triton X-100 in PBS (blocking
solution). DsRed rabbit polyclonal antibody (Clontech) was diluted 1:400 in blocking
solution and absorbed to embryos overnight at 4°C. Embryos were washed at room
temperature eight times over two hours in 1% BSA, 1% DMSO, 0.1% TX-100 in PBS and
placed in blocking solution for 30 min. An anti-rabbit horseradish peroxidase (HRP)
antibody (Zymed) was diluted 1:500 in blocking solution and absorbed to the embryos
overnight at 4°C. Following incubation with the secondary antibody, the embryos were
washed as above and equilibrated for 15 min in diaminobenzidine (DAB) buffer (Roche).
Embryos were then stained with DAB staining solution (Roche). Embryos were imaged as
above for in situ hybridization.
5′-RACE Analysis
Total RNA was isolated from 5 to 10 RFP-positive embryos at 2 to 3 dpf using Trizol
reagent (Invitrogen, Carlsbad, CA), and cDNA amplification was performed using a 5′
RACE System (Invitrogen) according to the manufacturer’s instructions. First strand cDNA
was synthesized using a primer complementary to RFP: 5′-
GTAGATGAACTCGCCGTCCT-3′. After cDNA purification, a string of cytosines was
added to the 3′ end of the cDNA by the terminal deoxy transferase reaction. The dC-tailed
cDNA was amplified by nested PCR using an RFP complementary primer: 5′-
AATGGATCCGGAGCCGTACTGGAACTGAG-3′ and an abridged anchor primer that
recognizes the dC tail at the 3′ end of the cDNA. Nested PCR was performed with an
annealing temperature of 55°C for 30–35 cycles using Taq DNA polymerase (Promega).
PCR products were Topo-TA (Invitrogen) cloned and sequenced at the DNA Facility at
Iowa State University.
Genotyping and RT-PCR Analysis
Genotyping was based on PCR amplification of the junction fragments between the flanking
regions of the Tol2 transposon integration site and the Tol2 transposon. The locations of
primers are shown in Figure S2A and Figure S3A. Genomic DNA was extracted from 3 to 4
dpf embryos using the DNeasy Blood and Tissue DNA Extraction kit (Qiagen). The primers
used to amplify from appa gene were V2 jf-L: 5′-CCCATCATTCCTTCCTCAAGCA-3′
and V2 jf-R: 5′-TCCAGGCGCAATGCTGTGTTAC-3′. For aplp2 gene, primers were V3
jf-L: 5′-CAACACTTCCAGTTTCCCGCCTA-3′ and V3 jf-R: 5′-
CAGAAAGTTCAACGGTGGGGCAA-3′. The PCR primer used to amplify out from the
Tol2 transposon was Tol2-L: 5′-CGGCTGCCTGTGAGAGGCTT-3′. The PCR products
were gel purified and sequenced to confirm the amplified products.
RT-PCR analysis of total RNA was carried out from staged embryos, larvae, and adult
organs as described (McGrail et al., 2010). The sequences of primers used for PCR were as
follows: appa, forward 5′-GTGGAGGCCATGCTGAACGA-3′ in exon 4; appa, reverse 5′-
CGATGATGCCGTGGTGGATG-3′ in exon 9; aplp2, forward 5′-
CGCCATGTTCTGCGGGAAAC-3 in exon 2′; aplp2, reverse 5′-
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CAACCTCCACGATGCCGTGA-3′ in exon 16. Control primer sequences for ribosomal
protein S6 kinase b (rps6kb1) were forward 5′-CATGGCGACGGTGCGTTCAT-3′ and
reverse 5′-AGCTTGCCGCCCGTCTGAAA-3′.
Genomic Southern Blot Analyses
Genomic DNA was extracted from adult fish and nonradioactive Southern blot analysis
performed as previously described (McGrail et al., 2011). The sequences of primers used to
amplify digoxigenin-labeled PCR probes were as follows. A 297-bp probe for the appa gene
was amplified from genomic DNA using primers appa-L: 5′-
TCTGGACTGAAGCCTGATGA-3′ and appa-R: 5′-GGGGTTTTCATAGCCGTTCT-3′.
A 292-bp probe complementary to the aplp2 gene was amplified from genomic DNA using
primers aplp2-L: 5′-GCTCTGGCATGAACAGTCTG-3′ and aplp2-R: 5′-
CCGTACTGCCTCTTCCTCAG-3′. A 541-bp probe complementary to the RFP cDNA was
amplified from the GBT-R15 plasmid using primers rfp-L: 5′-
CGAGGACGTCATCAAGGAGT-3′ and rfp-R: 5′-CTTGGCCATGTAGGTGGTCT-3′.
Images of blots were captured on a ChemiDoc XRS imaging system.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
Genomic organization of zebrafish appa and aplp2 genes showing the location of Tol2 gene
trap integration sites and predicted polypeptides. A: Genomic structure of appa and aplp2.
Blue boxes indicate exons. Location of Tol2 gene trap insertion site is shown. Black
arrowheads indicate transposon arms. Purple, red and orange boxes represent the splice
acceptor (SA), red fluorescent protein cDNA (RFP), and transcriptional termination/poly
adenylation sequences (poly A), respectively. B: Schematic of domain organization of the
App proteins and their proteolytic processing. The predicted Appa-RFP and Aplp2-RFP
proteins contain nearly the entire ectodomain. Grey circles with attached lines represent the
lipid bilayer positioned at the transmembrane domain. HBD1/GFLD: heparin-binding
domain/growth factor like domain; Cu/Zn BD: copper- ad zinc- binding domain; DE: acidic-
rich domain; KPI: Kunitz protease inhibitor domain; α, β and γ: α-, β- and γ-secretase
cleavage sites; p3, α-secretase proteolytic product; Aβ: β-secretase proteolytic product,
amyloid β peptide; AICD, APP intracellular domain; YENPTY, conserved C-terminal
interaction motif.
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Fig. 2.
Phylogenetic and expression analysis of zebrafish appa and aplp2. A: Phylogenetic tree of
amyloid precursor proteins. Zebrafish Appa and Aplp2 are shown in bold. The horizontal
bars represent the percentage of amino acid substitutions required to generate the
corresponding tree. Ce, Caenorhabditis elegans; Dm, Drosophila melanogaster; Dr, Danio
rerio; Gg, Gallus gallus; Hs, Homo sapiens; Mm, Mus musculus; Xl, Xenopus laevis. B:
Relative expression levels of appa and aplp2 throughout zebrafish development and in adult
tissues as evaluated by reverse transcriptase-polymerase chain reaction. Expression of the
ribosomal protein S6 kinase b, polypeptide 1b (rps6kb1) gene was used as a control.
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Fig. 3.
Expression of appa and aplp2 in developing central and peripheral nervous system of 36 hpf
zebrafish embryos. A: Lateral view, appa expression in the eye lens, optic tectum, midbrain
tegmentum, hindbrain, and posterior lateral line ganglion. B: Dorsal view, appa expression
in the cerebellar plate and ganglia. C: Lateral view, appa expression in the neural tube and
lateral line neuromasts (arrowheads). Line labeled “F” refers to position of cross-section
shown in panel F. D: Camera lucida drawing of 35 hours post fertilization (hpf) zebrafish
embryo (Kimmel et al., 1995). Line labeled “E, J” refers to position of cross-sections in
panels E and J. E: appa expression in the posterior lateral line ganglia and lateral regions of
medulla oblongata (arrowheads). F: appa expression in the neural tube, neuromasts of the
lateral line, and pronephric ducts. G: Lateral view of aplp2 expression in the epiphysis,
olfactory placode, cerebellum, ganglia, and neural tube. Line labeled “K” refers to position
of cross-section shown in panel K. H: Dorsal view, aplp2 expression in the epiphysis,
trigeminal ganglia, and ganglia in the hindbrain. I: Lateral view, aplp2 expression in the
trigeminal ganglia, anterodorsal and posterior lateral line ganglia. J: aplp2 expression in
posterior lateral line ganglion and lateral regions of medulla oblongata (arrowheads). K:
aplp2 expression in lateral regions of the neural tube, floor plate, and pronephric duct. Inset
shows higher magnification view of boxed region of neural tube. Arrow points to expression
of aplp2 in the floor plate region. ADLG, anterodorsal lateral line ganglia; Cb, cerebellum;
CeP, cerebellar plate; EL, eye lens; Ep, epiphysis; FP, floor plate; Ga, ganglion; Hb,
Hindbrain; MO, medulla oblongata; MT, midbrain tegmentum; NL, neuromasts of lateral
line; NT, neural tube; Op, olfactory placode; OT, optic tectum; PD, pronephric duct; PLLG,
posterior lateral line ganglion; TG, trigeminal ganglia. Scale bars = 50 μm.
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Fig. 4.
Red fluorescent protein (RFP) expression in the Appais22Gt gene trap line. A–G,I:
Fluorescence images of live Appais22Gt; Tg(flk1:moesin-gfp)is1 embryos. A: Appa-RFP was
detected throughout the veins and weakly in CNS and neural tube in 34 hours post
fertilization (hpf) embryos. B: Enlargement of boxed area in (A) shows RFP fluorescence in
the caudal vein and intersegmental vessels. C–F: Appa-RFP localization at 32 hpf embryos
in the trunk (C,D) and the head (E,F). Appa-RFP fluorescence overlaps with GFP expression
in endothelial cells in the veins (C,E), but not the arterial vessels (MTA, PPrA, LDA marked
with yellow arrows in E). H: Immunolocalization with anti-RFP antibody shows Appa-RFP
is localized to the caudal vein but absent from the dorsal aorta. G,I: Confocal images of
cross-section through the trunk of a 36 hpf embryo shows Appa-RFP accumulation in the
posterior caudal vein. CCV, common cardinal vein; CV, caudal vein; LDA, lateral dorsal
aorta; MCeV, midcerebral vein; MtA, metencephalic artery; NT, neural tube; PHBC,
primordial hindbrain channel; PPrA, primitive prosencephalic artery. Scale bars = 20 μm in
C,D, 50 μm in E–I.
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Fig. 5.
Red fluorescent protein (RFP) expression in the aplp2is23Gt gene trap line. Fluorescence
images of live aplp2is23Gt; Tg(flk1:moesin-gfp)is1 embryos. A: Aplp2-RFP fluorescence in
the caudal vein and intersegmental vessels in a 34 hours post fertilization (hpf) embryo. B:
Enlargement of boxed area in (A). C–F: RFP fluorescence at 32 hpf was observed in the
trunk (C,D) and the head (E,F). C,E: Aplp2-RFP fluorescence overlaps with green
fluorescent protein (GFP) expression in endothelial cells in the veins, but not the arterial
vessels (MTA, PPrA, LDA marked with yellow arrows in E). Weak expression is detected in
the dorsal aorta. H: Immunolocalization with anti-RFP antibody shows Appa-RFP was in
the caudal vein but absent from the dorsal aorta. G,I: Confocal images of cross-sections
through the trunk of 36 hpf embryo shows Aplp2-RFP accumulation at the posterior caudal
vein. CV, caudal vein; LDA, lateral dorsal aorta; MCeV, midcerebral vein; MtA,
metencephalic artery; PHBC, primordial hindbrain channel; PMBC, primordial midbrain
channel; PPrA, primitive prosencephalic artery. Scale bars = 20 μm in C,D, 50 μm in E–I.
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